$PKTX
ProtoKinetix, Inc. Stock $pktx

$pktx Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000107997324000403 Filed on March 20, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$44.08K	$61.18K
YoY Change	-40.16%	-87.9%
% of Gross Profit
Research & Development	$36.63K	$36.49K	$112.4K
YoY Change	61.49%	66.54%	-74.95%
% of Gross Profit
Depreciation & Amortization	$11.32K	$14.81K	$48.26K
YoY Change	5.79%	-73.65%	-17.43%
% of Gross Profit
Operating Expenses	$92.03K	$112.5K	$415.5K
YoY Change	-14.02%	-80.73%	-78.22%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$92.03K	-$112.5K
YoY Change	-14.02%	-80.73%
Income Tax
% Of Pretax Income
Net Earnings	-$92.03K	-$112.5K	-$415.5K
YoY Change	-14.02%	-80.73%	-78.22%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01		-$0.01
Diluted Earnings Per Share	-$0.01	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	346.7M shares	338.9M shares	333.1M shares
Diluted Shares Outstanding	333.1M shares		333.1M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.840K	$20.41K	$20.41K
YoY Change	-59.08%	-20.12%	-20.12%
Cash & Equivalents	$2.836K	$20.41K
Short-Term Investments
Other Short-Term Assets	$1.050K	$1.050K	$1.050K
YoY Change	0.0%	0.0%	0.0%
Inventory
Prepaid Expenses	$1.050K	$1.050K
Receivables
Other Receivables
Total Short-Term Assets	$3.886K	$21.46K	$21.46K
YoY Change	-51.38%	-19.33%	-19.32%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$457.5K	$459.1K	$459.1K
YoY Change	4.14%	5.23%	5.23%
TOTAL ASSETS
Total Short-Term Assets	$3.886K	$21.46K	$21.46K
Total Long-Term Assets	$457.5K	$459.1K	$459.1K
Total Assets	$461.4K	$480.6K	$480.6K
YoY Change	3.15%	3.82%	3.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$67.57K	$44.70K	$44.70K
YoY Change	27.49%	7.62%	7.63%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$67.57K	$44.70K	$44.70K
YoY Change	27.49%	7.62%	7.63%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$67.57K	$44.70K	$44.70K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$67.57K	$44.70K	$44.70K
YoY Change	27.49%	7.63%	7.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$47.96M	-$47.86M
YoY Change	0.84%	0.88%
Common Stock	$1.874K	$1.850K
YoY Change	7.27%	7.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$393.8K	$435.9K	$435.9K
YoY Change
Total Liabilities & Shareholders Equity	$461.4K	$480.6K	$480.6K
YoY Change	3.15%	3.82%	3.82%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$92.03K	-$112.5K	-$415.5K
YoY Change	-14.02%	-80.73%	-78.22%
Depreciation, Depletion And Amortization	$11.32K	$14.81K	$48.26K
YoY Change	5.79%	-73.65%	-17.43%
Cash From Operating Activities	-$57.84K	-$77.47K	-$376.0K
YoY Change	-31.85%	-47.36%	-53.27%
INVESTING ACTIVITIES
Capital Expenditures	$9.740K	$24.52K	$59.15K
YoY Change	-29.11%	-57.35%	-55.21%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$9.736K	-$24.52K	-$59.15K
YoY Change	-29.16%	-57.35%	-55.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$251.0K
YoY Change			-72.26%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$50.00K	110.0K	$430.0K
YoY Change	-37.5%	-41.02%	-52.47%
NET CHANGE
Cash From Operating Activities	-$57.84K	-77.47K	-$376.0K
Cash From Investing Activities	-$9.736K	-24.52K	-$59.15K
Cash From Financing Activities	$50.00K	110.0K	$430.0K
Net Change In Cash	-$17.57K	8.010K	-$5.142K
YoY Change	-5.57%	-144.11%	-83.94%
FREE CASH FLOW
Cash From Operating Activities	-$57.84K	-$77.47K	-$376.0K
Capital Expenditures	$9.740K	$24.52K	$59.15K
Free Cash Flow	-$67.58K	-$102.0K	-$435.1K
YoY Change	-31.47%	-50.17%	-53.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001128189
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023	PKTX	Fair Value Of Compensatory Options Granted FairValueOfCompensatoryOptionsGranted		usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther		usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	PKTX	There Were Shares Issued In Settlement Of Shareholder Advance ThereWereSharesIssuedInSettlementOfShareholderAdvance		usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense		usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		usd
CY2022	PKTX	Income Tax Reconciliation Expiration Of Losses IncomeTaxReconciliationExpirationOfLosses		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Registrant Name EntityRegistrantName	PROTOKINETIX, INCORPORATED
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-3355026
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	109 W Main St
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Dalton
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	44618
CY2023	dei	City Area Code CityAreaCode	330
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	6856188	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	346713485	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	731
CY2023	dei	Auditor Name AuditorName	DAVIDSON & COMPANY LLP
CY2023	dei	Auditor Location AuditorLocation	Vancouver, Canada
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	20408	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	25550	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1050	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1050	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	21458	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	26600	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	459099	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	436270	usd
CY2023Q4	us-gaap	Assets Assets	480557	usd
CY2022Q4	us-gaap	Assets Assets	462870	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	44696	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	41530	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44696	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	41530	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0000053
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0000053
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	346213485	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	346213485	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	322880151	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	322880151	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1850	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1726	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	48297969	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	47868093	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47863958	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47448479	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	435861	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	421340	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	480557	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	462870	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	48259	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	58450	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	99619	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	162749	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	155157	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	166254	usd
CY2015	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	25000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	448873	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1070983	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1907309	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	333102754	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	333102754	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	307392069	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	307392069	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	352966	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1070983	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	904700	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1907309	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	421340	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	421340	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	430000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-415479	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	435861	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-415479	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1907309	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	48258	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	58450	usd
CY2022	PKTX	Fair Value Of Compensatory Options Granted FairValueOfCompensatoryOptionsGranted	1070983	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-24945	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8768	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-51738	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-375989	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-804669	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	59153	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	132049	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-59153	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-132049	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	251000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	904700	usd
CY2023	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	179000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	430000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	904700	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5142	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-32018	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25550	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57568	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20408	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25550	usd
CY2023	PKTX	There Were Shares Issued In Settlement Of Shareholder Advance ThereWereSharesIssuedInSettlementOfShareholderAdvance	179000	usd
CY2023	PKTX	Intangible Asset Costs Remaining In Accounts Payable IntangibleAssetCostsRemainingInAccountsPayable	11934	usd
CY2015	PKTX	Payment To Acquire Intangible Assets PaymentToAcquireIntangibleAssets	30000	usd
CY2015Q4	PKTX	Additional Patent Applications AdditionalPatentApplications	10000	usd
CY2015	PKTX	Warrant Issued WarrantIssued	6000000	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-47863958	usd
CY2023Q4	PKTX	Working Capital Deficiency WorkingCapitalDeficiency	23238	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_zoQsxWpfpkQ5" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_869_zMHF4GE4lwyk">Use of Estimates</span></span></b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The more significant accounting estimates inherent in the preparation of the Company's financial statements include estimates as to valuation of equity- related instruments issued, deferred income taxes and the useful life and impairment of intangible assets.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Deposits Assets DepositsAssets	1050	usd
CY2022Q4	us-gaap	Deposits Assets DepositsAssets	1050	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	382171	usd
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	132049	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	514220	usd
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	71088	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	585308	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19500	usd
CY2022	PKTX	Amortization Amortization	58450	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	77950	usd
CY2023	PKTX	Amortization Amortization	48259	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	126209	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	436270	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	459099	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	48259	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	58450	usd
CY2015Q4	PKTX	Additional Patent Applications AdditionalPatentApplications	10000	usd
CY2015	PKTX	Warrant Issued WarrantIssued	6000000	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1070983	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.03
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0350	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.4343	pure
CY2023	PKTX	Expected Forfeiture Rate ExpectedForfeitureRate	0.0000	pure
CY2022	PKTX	Expected Forfeiture Rate ExpectedForfeitureRate	0.0000	pure
CY2022	PKTX	Sharebased Compensation Arrangement By Sharebased Paymenst Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymenstAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	94290000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	94290000	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13300000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0000053
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0000053
CY2023Q4	us-gaap	Dividends Receivable DividendsReceivable	0	usd
CY2022Q4	us-gaap	Dividends Receivable DividendsReceivable	0	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5250000	shares
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P8Y
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.06
CY2022Q1	PKTX	Options Expiration Date OptionsExpirationDate	2030-03-14
CY2023	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	0	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	955451	usd
CY2023	PKTX	Modification Incremental Fair Value Option ModificationIncrementalFairValueOption	0	usd
CY2022	PKTX	Modification Incremental Fair Value Option ModificationIncrementalFairValueOption	1070983	usd
CY2023Q4	PKTX	Due To Related Parties Currents DueToRelatedPartiesCurrents	0	usd
CY2022Q4	PKTX	Due To Related Parties Currents DueToRelatedPartiesCurrents	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-415479	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1907309	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	87250	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	400535	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	224907	usd
CY2023	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-257615	usd
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	75628	usd
CY2023	PKTX	Income Tax Reconciliation Expiration Of Losses IncomeTaxReconciliationExpirationOfLosses	3124	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	341741	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	100000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6253860	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	6400000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6253860	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6400000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	29800000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	30500000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6296352	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6400000	usd

Files In Submission

Name	View Source	Status
0001079973-24-000403-index-headers.html	Edgar Link	pending
0001079973-24-000403-index.html	Edgar Link	pending
0001079973-24-000403.txt	Edgar Link	pending
0001079973-24-000403-xbrl.zip	Edgar Link	pending
davidson.jpg	Edgar Link	pending
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32x1.htm	Edgar Link	pending
ex4x6.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pktx-20231231.xsd	Edgar Link	pending
pktx_10k.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pktx-20231231_cal.xml	Edgar Link	unprocessable
pktx-20231231_def.xml	Edgar Link	unprocessable
pktx-20231231_lab.xml	Edgar Link	unprocessable
pktx-20231231_pre.xml	Edgar Link	unprocessable
pktx_10k_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PKTX
ProtoKinetix, Inc. Stock $pktx

2024 Q1 Form 10-K Financial Statement

#000107997324000403 Filed on March 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PKTX ProtoKinetix, Inc. Stock $pktx

2024 Q1 Form 10-K Financial Statement

#000107997324000403 Filed on March 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PKTX
ProtoKinetix, Inc. Stock $pktx